BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38223098)

  • 1. A fusion model integrating magnetic resonance imaging radiomics and deep learning features for predicting alpha-thalassemia X-linked intellectual disability mutation status in isocitrate dehydrogenase-mutant high-grade astrocytoma: a multicenter study.
    Liu Z; Xu X; Zhang W; Zhang L; Wen M; Gao J; Yang J; Kan Y; Yang X; Wen Z; Chen S; Cao X
    Quant Imaging Med Surg; 2024 Jan; 14(1):251-263. PubMed ID: 38223098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter clinical radiomics-integrated model based on [
    Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
    Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
    Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
    Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI.
    Gao J; Liu Z; Pan H; Cao X; Kan Y; Wen Z; Chen S; Wen M; Zhang L
    J Magn Reson Imaging; 2024 May; 59(5):1655-1664. PubMed ID: 37555723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.
    Sohn B; An C; Kim D; Ahn SS; Han K; Kim SH; Kang SG; Chang JH; Lee SK
    J Neurooncol; 2021 Dec; 155(3):267-276. PubMed ID: 34648115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
    Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
    Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.
    Karabacak M; Ozkara BB; Mordag S; Bisdas S
    Quant Imaging Med Surg; 2022 Aug; 12(8):4033-4046. PubMed ID: 35919062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
    Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
    J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep-learning and conventional radiomics to predict
    Zhang H; Fan X; Zhang J; Wei Z; Feng W; Hu Y; Ni J; Yao F; Zhou G; Wan C; Zhang X; Wang J; Liu Y; You Y; Yu Y
    Front Oncol; 2023; 13():1143688. PubMed ID: 37711207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
    Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
    Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-tumor histogram analysis of synthetic magnetic resonance imaging predicts isocitrate dehydrogenase mutation status in gliomas.
    Ge X; Gan T; Yang Z; Liu G; Hu W; Ma W; Bai Y; Xiong Y; Li M; Zhao J; Zhou L; Li J; Li D; Wang X; Zhang J
    Quant Imaging Med Surg; 2024 Mar; 14(3):2225-2239. PubMed ID: 38545061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma.
    Sun C; Fan L; Wang W; Wang W; Liu L; Duan W; Pei D; Zhan Y; Zhao H; Sun T; Liu Z; Hong X; Wang X; Guo Y; Li W; Cheng J; Li Z; Liu X; Zhang Z; Yan J
    Front Oncol; 2021; 11():756828. PubMed ID: 35127472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal-based machine learning strategy for accurate and non-invasive prediction of intramedullary glioma grade and mutation status of molecular markers: a retrospective study.
    Ma C; Wang L; Song D; Gao C; Jing L; Lu Y; Liu D; Man W; Yang K; Meng Z; Zhang H; Xue P; Zhang Y; Guo F; Wang G
    BMC Med; 2023 May; 21(1):198. PubMed ID: 37248527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
    Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
    Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.